Diclofenac and Misoprostol Interaction

Understanding the Diclofenac and Misoprostol Interaction

FDA-approved prescribing information for these two drugs flags their combination as a moderate-severity interaction. Diclofenac belongs to the Nonsteroidal Anti-Inflammatory Drug (NSAID) class and Misoprostol belongs to the Prostaglandin E1 Analog class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Diclofenac can increase the risk of serious bleeding in the stomach. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.

Context around a specific patient determines real-world impact. Diclofenac has 11 total documented interactions on file in this dataset, and Misoprostol has 12. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Take this combination exactly as your doctor tells you to help prevent stomach ulcers and bleeding. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.

An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Diclofenac or Misoprostol based on a web page, speak with your prescriber or pharmacist before making any change.